AbFero Receives Funding to Advance Iron-trapping Parkinson’s Disease Therapy
AbFero Ltd will receive approximately €2 million ($2.41 million) through Eureka Network’s Eurostars program to complete pre-clinical…
Articles by Forest Ray PhD
New Technique Isolates Specific Neurons, Finds Changes in Parkinson’s
A new technique to isolate specific brain cells, used in a Parkinson’s mouse model, has revealed that genes involved…
Mitochondrial Interaction Networks May Help in Diagnosing Parkinson’s
Networks of mitochondrial interactions in nerve cells may be used as a biomarker in diagnosing Parkinson’s disease, a recent study has…
Automated Process Grows 3D Organoids – ‘Mini-brains’ – to Test Potential Therapies
A fully automated process for growing three-dimensional (3D) midbrain-like organoids — a “mini-organ” model of the brain — has…
Computer Model May Help in Better Tailoring Levodopa Dose to Patient’s Needs
A computational model of how Parkinson’s disease evolves over time may help guide physicians in tailoring levodopa doses to…
Anti-nausea Medicine Ondansetron Will Be Tested for Treating Hallucinations
Ondansetron, an anti-nausea medication usually prescribed to those undergoing cancer therapies, will be tested in an upcoming Phase 2…
Pharmather Seeking FDA Orphan Drug Designation for Ketamine for Dyskinesia
Pharmather filed an application with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation be given…
Gut Bacteria May Cause Constipation Associated With Levodopa in Parkinson’s Patients
Scientists found a species of bacteria living in the small intestine, called Clostridium sporogenes, that is able to convert…
Buspirone Eases Anxiety, But Tolerability Seen as Problem in Small Trial
Buspirone can effectively ease anxiety among people with Parkinson’s disease, but the medication is not well tolerated, according to…
Kynmobi Sublingual Film for ‘Off’ Episodes Now Available in US
Kynmobi (apomorphine hydrochloride), a sublingual film to treat “off” episodes in people with Parkinson’s disease, is now available…